🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Single-Center Prospective Study to Investigate the Difference in the Incidence of Contrast-Induced Nephropathy in High-Risk Patients With the Use of the Dye-Vert Plus System

RecruitingPhase 4Ages 18 Years - 90 YearsAllCAMC Health System
NCT04279457 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Coronary angiography (CAG) for diagnostic or therapeutic purposes such as percutaneous coronary intervention (PCI) is one of the common procedures which require the use of intravenous contrast media. The reported incidence of contrast induced nephropathy (CIN) in high-risk patients following CAG varies from 10% to 30%. The high rate of CIN in post-PCI patients could be related either to the patient (advanced age, previous CKD, diabetes, dehydration, and concomitant use of other nephrotoxic drugs) or procedure related (intra-arterial route of administration, use of high osmolar contrast media, repeated exposure to contrast within 48 hours, volume of contrast used). Several strategies to prevent or treat CIN have been developed, including hydration, N-acetyl-cysteine, statins, ascorbic acid, bicarbonate, aminophylline, forced diuresis, renal replacement therapy, and choice of low-osmolarit

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Inclusion criteria: 1. 18 years of age or older 2. Scheduled to undergo CAG and/or PCI 3. Baseline estimated glomerular filtration rate (eGFR) of ≥20 and ≤60 mL/ min/1.73 m2 4. Serum creatinine \> 1.5mg/dl 5. Obtaining a Cardiac catheterization. 6. HTN/Diabetes 7. Inpatient and outpatient Exclusion Criteria: * Exclusion criteria: 1. 91 years of age or older 2. Serum creatinine \< 1.5mg/dl 3. eGFR \> 60ml/min 4. Pregnancy 5. Dialysis 6. Dye Allergy
💊

What it tests

  • DyeVert Plus System
  • Standardized hydration protocol
📍

Where

1 site
CAMC Health Education and Research Institute
Charleston, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy